Necrolytic migratory erythema following prolonged continuous subcutaneous dasiglucagon administration: a rare dermatologic adverse event

Clinical management of congenital hyperinsulinism (CHI) remains a significant challenge due to its complex pathophysiology and the limitations of available therapies. Dasiglucagon, a synthetic glucagon analog, represents a novel approach to managing CHI, particularly in patients where conventional t...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Lucas Weschle, Jenny Potratz, Frank Rutsch, Alexander Humberg, Sandra Oesingmann, Andreas Pascher, Alexander S Busch, Katja Masjosthusmann
Format:	Artigo
Jezik:	Inglês
Izdano:	Bioscientifica 2025-04-01
Serija:	Endocrinology, Diabetes & Metabolism Case Reports
Teme:	necrolytic migratory erythema dasiglucagon congenital hyperinsulinism neonatal hypoglycemia
Online dostop:	https://edm.bioscientifica.com/view/journals/edm/2025/2/EDM-25-0006.xml
Oznake:	Označite Brez oznak, prvi označite!